← SynDRA
ANDROSTERONE
SynDRA canonical compound SYN0003465 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | androgen receptor agonist |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- GPBAR1
- SERPINA6
- SHBG
- ESR1
- ACHE
- MMP1
- PPP3CA
- POLI
- PDE5A
- OPRM1
- OPRK1
- OPRD1
- NR3C1
- NPY2R
- NPY1R
- MMP9
- MC5R
- PTAFR
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- KAT2A
- HTR6
- HTR2C
- PRKCA
- PTGS1
- HTR2A
- UGT1A10
- USP1
- UGT2B7
- UGT2B4
- UGT2B17
- UGT2B15
- UGT2B10
- UGT1A9
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP2C9
- ESRRA
- GLI3
- NR1I2
- PRGR
Cross-references
Synonyms
- Androkinine
- Androtine
- 5alpha-Androsterone
- Atromide ICI
- 3alpha-Hydroxy-5alpha-androstan-17-one
- 3-Epihydroxyetioallocholan-17-one
- cis-Androsterone
- 3alpha-Hydroxyetioallocholan-17-one
- 5alpha-Androstane-3alpha-ol-17-one
- 3alpha-Hydroxy-17-androstanone
- Androstanon-3-alpha-ol-17-one
- 3-alpha-Hydroxy-17-androstanone
- 3-alpha-Hydroxyetioallocholan-17-one
- 3-alpha-Hydroxy-5-alpha-androstan-17-one
- 5-alpha-Androstan-3-alpha-ol-17-one
- Caswell No. 051G
- Androstan-17-one, 3-hydroxy-, (3alpha,5alpha)-
- 3 alpha Hydroxy 5 alpha Androstan 17 One
- (3alpha,5alpha)-3-hydroxyandrostan-17-one
- C24W7J5D5R
- CHEBI:16032
- NSC 9898
- DTXCID1016525
- RefChem:112651
- Androstan-17-one, 3-hydroxy-, (3a,5a)-
- 5alpha-Androstan-17-one, 3alpha-hydroxy-
- 5alpha-Androstan-3alpha-ol-17-one
- 5.alpha.-Androsterone
- Androstan-17-one, 3-hydroxy-, (3-alpha,5-alpha)-
- 3.alpha.-Hydroxy-17-androstanone
- U 6036
- MLS000069394
- 5-alpha-Androstan-17-one, 3-alpha-hydroxy-
- 3.alpha.-Hydroxyetioallocholan-17-one
- SMR000058571
- 5.alpha.-Androstane-3.alpha.-ol-17-one
- 5.alpha.-Androstan-17-one, 3.alpha.-hydroxy-
Look up ANDROSTERONE in the interactive SynDRA portal →